MedTrace Logo

Obstructive Sleep Apnoea in Patients With Type 1 Diabetes

NCT03481361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2020-09-07

No results posted yet for this study

Summary

The primary aim of this study is to assess the relationship between obstructive sleep apnoea (OSA) and cardiac autonomic neuropathy (CAN) in patients with T1D.

The secondary aims of this study are to assess: (1) the prevalence of OSA in patients with T1D; (2) the relationship between OSA and metabolic parameters (such as glycaemic control, blood pressure, lipids and weight) in patients with T1D; (3) the relationship between OSA and diabetes-related microvascular complications (retinopathy, nephropathy, peripheral neuropathy) in patients with T1D; and (4) the potential mechanisms for the relationship between OSA and diabetic-related complications if such a relationship is found.

Conditions

Sponsors & Collaborators

  • Heart of England NHS Trust

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Abd Tahrani, MD · NIHR Clinician Scientist at University of Birmingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-14
Primary Completion
2019-06-27
Completion
2019-06-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03481361 on ClinicalTrials.gov